Discontinued — last reported Q3 '20
Philip Morris International Finite-Lived Intangible Assets - Expected Amortization Expense (Year Four) decreased by 0.1% to $996.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from $993.00M to $996.00M.
A decrease suggests lower future non-cash charges, potentially boosting reported net income, while an increase reflects significant recent asset acquisitions.
This represents the projected non-cash expense associated with the amortization of finite-lived intangible assets, such...
Standard disclosure for pharmaceutical companies with significant M&A activity and R&D pipelines.
finite_lived_intangible_assets_amortization_year_4| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $75.00M | $143.00M | $150.00M | $145.00M | $127.00M | $322.00M | $322.00M | $460.00M | $479.00M | $1.03B | $993.00M | $994.00M | $997.00M | $996.00M |
| QoQ Change | — | +90.7% | +4.9% | -3.3% | -12.4% | +153.5% | +0.0% | +42.9% | +4.1% | +115.2% | -3.7% | +0.1% | +0.3% | -0.1% |
| YoY Change | — | — | — | +93.3% | -11.2% | +114.7% | +122.1% | +262.2% | +48.8% | +220.2% | +115.9% | +107.5% | -3.3% | +0.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.